dalteparin has been researched along with Apolipoprotein B-100, Familial Defective in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lorenzini, JL | 1 |
| Dutrillaux, F | 1 |
| Mousson, C | 1 |
| Lassale, B | 1 |
| Maynadié, M | 1 |
| Rifle, G | 1 |
1 other study available for dalteparin and Apolipoprotein B-100, Familial Defective
| Article | Year |
|---|---|
Extracorporeal circuit heparinization in selective low density lipoprotein apheresis: changes in patient hemostasis and low molecular weight heparin benefit.
Topics: Adult; Blood Coagulation Factors; Blood Component Removal; Dextran Sulfate; Extracorporeal Circulati | 1993 |